BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24639860)

  • 1. Trans fatty acids - A risk factor for cardiovascular disease.
    Iqbal MP
    Pak J Med Sci; 2014 Jan; 30(1):194-7. PubMed ID: 24639860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trans fatty acids: are its cardiovascular risks fully appreciated?
    Nestel P
    Clin Ther; 2014 Mar; 36(3):315-21. PubMed ID: 24636816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trans-Fatty Acid (TFA) elimination in Pakistan: A situational analysis.
    Rashid A; Amjad S; Nishtar MK; Nishtar NA
    J Pak Med Assoc; 2020 May; 70(Suppl 2)(5):S1-S30. PubMed ID: 33144736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consumption of trans fats and estimated effects on coronary heart disease in Iran.
    Mozaffarian D; Abdollahi M; Campos H; Houshiarrad A; Willett WC
    Eur J Clin Nutr; 2007 Aug; 61(8):1004-10. PubMed ID: 17268422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of the TRANSFACT project phase I: a study to assess the effect of the two different dietary sources of trans fatty acids on cardiovascular risk factors in humans.
    Chardigny JM; Malpuech-Brugère C; Dionisi F; Bauman DE; German B; Mensink RP; Combe N; Chaumont P; Barbano DM; Enjalbert F; Bezelgues JB; Cristiani I; Moulin J; Boirie Y; Golay PA; Giuffrida F; Sébédio JL; Destaillats F
    Contemp Clin Trials; 2006 Aug; 27(4):364-73. PubMed ID: 16632411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and application of the TFA macrosimulation model: a case study of modelling the impact of trans fatty acid (TFA) elimination policies in Brazil.
    Nilson EAF; Khandpur N; da Silva Gomes F
    BMC Public Health; 2022 Nov; 22(1):2010. PubMed ID: 36324096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils.
    Mozaffarian D; Clarke R
    Eur J Clin Nutr; 2009 May; 63 Suppl 2():S22-33. PubMed ID: 19424216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health effects of trans-fatty acids: experimental and observational evidence.
    Mozaffarian D; Aro A; Willett WC
    Eur J Clin Nutr; 2009 May; 63 Suppl 2():S5-21. PubMed ID: 19424218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of trans fatty acids in health and challenges to their reduction in Indian foods.
    Ghafoorunissa G
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():212-5. PubMed ID: 18296340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruminant and industrial trans-fatty acids consumption and cardiometabolic risk markers: A systematic review.
    Verneque BJF; Machado AM; de Abreu Silva L; Lopes ACS; Duarte CK
    Crit Rev Food Sci Nutr; 2022; 62(8):2050-2060. PubMed ID: 33081490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the complexities of prevalence of trans fat and its control in food supply in Pakistan.
    Tarar OM; Ahmed KM; Nishtar NA; Achakzai ABK; Gulzar Y; Delles C; Al-Jawaldeh A
    J Clin Hypertens (Greenwich); 2020 Aug; 22(8):1338-1346. PubMed ID: 32687252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid composition including trans-fatty acids in edible oils and fats: probable intake in Indian population.
    Dixit S; Das M
    J Food Sci; 2012 Oct; 77(10):T188-99. PubMed ID: 22950538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans-Fatty Acids and Cardiovascular Disease: Urgent Need for Legislation.
    Wilczek MM; Olszewski R; Krupienicz A
    Cardiology; 2017; 138(4):254-258. PubMed ID: 28946140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trans fatty acids: current contents in Canadian foods and estimated intake levels for the Canadian population.
    Ratnayake WM; L'Abbe MR; Farnworth S; Dumais L; Gagnon C; Lampi B; Casey V; Mohottalage D; Rondeau I; Underhill L; Vigneault M; Lillycrop W; Meleta M; Wong LY; Ng T; Gao Y; Kwong K; Chalouh S; Pantazopoulos P; Gunaratna H; Rahardja A; Blagden R; Roscoe V; Krakalovich T; Neumann G; Lombaert GA
    J AOAC Int; 2009; 92(5):1258-76. PubMed ID: 19916364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of trans fatty acids: biochemistry and health effects.
    Bhardwaj S; Passi SJ; Misra A
    Diabetes Metab Syndr; 2011; 5(3):161-4. PubMed ID: 22813572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccenic acid and trans fatty acid isomers from partially hydrogenated oil both adversely affect LDL cholesterol: a double-blind, randomized controlled trial.
    Gebauer SK; Destaillats F; Dionisi F; Krauss RM; Baer DJ
    Am J Clin Nutr; 2015 Dec; 102(6):1339-46. PubMed ID: 26561632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review.
    Hunter JE; Zhang J; Kris-Etherton PM
    Am J Clin Nutr; 2010 Jan; 91(1):46-63. PubMed ID: 19939984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Trans-fatty acids--effects on coronary heart disease].
    Karbowska J; Kochan Z
    Pol Merkur Lekarski; 2011 Jul; 31(181):56-9. PubMed ID: 21870712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consumption of Oxidized and Partially Hydrogenated Oils Differentially Induces Trans-Fatty Acids Incorporation in Rats' Heart and Dyslipidemia.
    Dhibi M; Mnari A; Brahmi F; Houas Z; Chargui I; Kharroubi W; Hammami M
    J Am Coll Nutr; 2016; 35(2):125-35. PubMed ID: 25794039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intake of
    Restrepo BJ
    Public Health Nutr; 2020 Apr; 23(6):1103-1107. PubMed ID: 31918772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.